Anlotinib Hydrochloride Versus Imatinib Mesylate in Locally Advanced, Unresectable or Metastatic Chordoma
Conditions: Effect of Drugs; Quality of Life; Chordoma; Advanced Cancer Intervention: Drug: Anlotinib Hydrochloride Sponsors: Peking University People's Hospital; Peking University Shougang Hospital; Peking University Third Hospital; Peking University First Hospital; Beijing Jishuitan Hospital; Chinese PLA General Hospital; Beijing Cancer Hospital; Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2019 Category: Research Source Type: clinical trials
Pemetrexed for the Treatment of Chordoma
Condition: Chordoma Intervention: Drug: Pemetrexed Sponsors: John Wayne Cancer Institute; Eli Lilly and Company Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 17, 2019 Category: Research Source Type: clinical trials
